Thiberville Simon-Djamel, Schilling Stefan, De Iaco Giuseppina, Fusco Francesco Maria, Thomson Gail, Maltezou Helen C, Gottschalk Rene, Brodt Reinhard H, Bannister Barbara, Puro Vincenzo, Ippolito Giuseppe, Brouqui Philippe
UMR 190, Emergence of Viral Pathologies, Aix-Marseille Univ-IRD-EHESP French School of Public Health, Marseille, France.
BMC Res Notes. 2012 Sep 25;5:527. doi: 10.1186/1756-0500-5-527.
Highly infectious diseases (HIDs) are defined as being transmissible from person to person, causing life-threatening illnesses and presenting a serious public health hazard. The sampling, handling and transport of specimens from patients with HIDs present specific bio-safety concerns.
The European Network for HID project aimed to record, in a cross-sectional study, the infection control capabilities of referral centers for HIDs across Europe and assesses the level of achievement to previously published guidelines. In this paper, we report the current diagnostic capabilities and bio-safety measures applied to diagnostic procedures in these referral centers. Overall, 48 isolation facilities in 16 European countries were evaluated. Although 81% of these referral centers are located near a biosafety level 3 laboratory, 11% and 31% of them still performed their microbiological and routine diagnostic analyses, respectively, without bio-safety measures.
The discrepancies among the referral centers surveyed between the level of practices and the European Network of Infectious Diseases (EUNID) recommendations have multiple reasons of which the interest of the individuals in charge and the investment they put in preparedness to emerging outbreaks. Despite the fact that the less prepared centers can improve by just updating their practice and policies any support to help them to achieve an acceptable level of biosecurity is welcome.
高传染性疾病(HIDs)被定义为可在人与人之间传播,导致危及生命的疾病,并构成严重的公共卫生危害。对高传染性疾病患者标本的采样、处理和运输存在特定的生物安全问题。
欧洲高传染性疾病网络项目旨在通过一项横断面研究,记录欧洲各地高传染性疾病转诊中心的感染控制能力,并评估其对先前发布指南的执行水平。在本文中,我们报告了这些转诊中心目前应用于诊断程序的诊断能力和生物安全措施。总体而言,对16个欧洲国家的48个隔离设施进行了评估。尽管这些转诊中心中有81%位于生物安全3级实验室附近,但仍分别有11%和31%的中心在没有生物安全措施的情况下进行微生物学和常规诊断分析。
接受调查的转诊中心在实践水平与欧洲传染病网络(EUNID)建议之间存在差异,原因是多方面的,其中包括相关负责人的关注度以及他们在应对新出现疫情方面的投入。尽管准备不足的中心只需更新其实践和政策就能有所改善,但任何有助于它们达到可接受生物安全水平的支持都是受欢迎的。